Tag: Acquisition
Business & Industry
Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal
Teva Pharmaceuticals has entered into a definitive agreement to acquire Emalex Biosciences, strengthening its neuroscience pipeline through the addition of ecopipam, a late-stage investigational...
BioPharma
Sun Pharma Organon Buyout Marks Largest Biopharma Deal 2026
Sun Pharmaceutical Industries has agreed to acquire Organon in a transaction valued at $11.75 billion, creating what the company described as the largest Biopharma...
Business & Industry
Eli Lilly Kelonia Acquisition Advances in $2B Deal Talks
Eli Lilly and Company is in advanced discussions to acquire Kelonia Therapeutics for more than $2 billion, according to a report by The Wall...
Business & Industry
Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal
Gilead Sciences has agreed to acquire Germany-based Tubulis in a deal valued at $3.15 billion upfront, with an additional $1.85 billion tied to milestones,...
Business & Industry
Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition
Neurocrine Biosciences is close to securing a more than $2.5bn acquisition of Soleno Therapeutics, the developer of a treatment for a rare genetic form...
Business & Industry
Biogen to Acquire Apellis for $5.6 Billion in Major Deal
Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, in a move that significantly expands its presence in immunology and rare...
Business & Industry
Transcend Acquisition Advances Otsuka Neuroplastogen Focus
Japanese pharmaceutical company Otsuka has moved to deepen its presence in the emerging neuroplastogen space through an agreement to acquire Transcend Therapeutics, bringing with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read